Mr. Paul Sullivan reports

TRUE LEAF ANNOUNCES INITIAL CLOSING OF ITS REGULATION A+ OFFERING

True Leaf Medicine International Ltd. has conducted an initial closing of its previously announced Regulation A+ offering for gross proceeds in the amount of $6.18-million for 8,883,590 shares.

True Leaf's Regulation A+ offering was qualified by the Securities and Exchange Commission (SEC) on Nov. 21, 2017, and allows the company to sell up to 14,285,715 common shares at an offering price of 70 cents per share in the United States. Boustead Securities, LLC, working with its affiliate, FlashFunders, is the lead managing selling agent and bookrunner for the offering. CrowdfundX is the digital marketing agency of record.

About True Leaf Medicine International Ltd.

Founded in 2013, True Leaf has two main operating divisions: True Leaf Medicine Inc. and True Leaf Pet Inc. True Leaf Medicine Inc. was launched in July, 2013, to become a licensed producer of medicinal cannabis for the Canadian market. True Leaf Medicine Inc. has been given approval by Health Canada to build its grow facility and will be subject to a Health Canada security inspection upon completion to allow for the cultivation, manufacture and distribution of cannabis products. Currently, True Leaf does not have a licence to produce cannabis.

We seek Safe Harbor.